San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Otonomy Eyes Swimmer’s Ear Market to Expand Use of Drug

Local drugmaker Otonomy Inc. is planning to ask the U.S. Food and Drug Administration for approval to sell its drug Otiprio for use in treating swimmer’s ear.

Tease photo

Palliative Care Comes In Life-Affirming Model

MEDICINE: Co. Guides Patient, Family Through Last Journey

Dr. Bob Uslander was meditating on a bluff in La Jolla in early 2013 when he was jolted by an epiphany that would transform his professional life.

Venture Capitalists Liked These 10 S.D. Companies Best

During 2016, San Diego saw 103 venture capital investments for a total of about $1.28 billion, according to a MoneyTree report released this week by PwC and CB Insights.

DexCom Reports Record Revenue of $570 Million for 2016

San Diego medical device maker DexCom Inc. has reported $570 million in revenue for its fiscal 2016, a 42 percent jump over 2015.

Scripps Research Institute, Pfizer Ink Licensing Agreement

The Scripps Research Institute has landed a deal with global drugmaker Pfizer Inc. in which Pfizer will use TSRI’s technology to find promising chemical leads for new drugs.

Teamsters to Strike All UC Facilities Jan. 10

A plan by the Teamsters union to conduct a one-day labor strike Jan. 10 by clerical workers across the University of California system has been met with recrimination by UC San Diego Health, which said it plans to keep its facilities open during what it called a potentially illegal job action.

Mirati Therapeutics Announces Pricing of Public Offering

San Diego-based Mirati Therapeutics Inc. said Jan. 6 that it priced its initial public offering at $5.60 per share, raising up to $65 million before underwriting and related expenses. The offering is expected to close Jan. 11.

Tease photo

Sharp's Chief Medical Officer Appointed to HQI Board

Sharp Chula Vista Medical Center’s chief medical officer has been appointed to a board that helps a number of state and regional groups improve industry performance and foster innovation.

Tease photo

Illumina, IBM to Deploy Watson to Take on Cancer Treatments

Illumina Inc. kicked off the J.P. Morgan Healthcare Conference with a bang Monday morning when the company announced a partnership with IBM Watson that could revolutionize cancer care.

Tease photo

Mast Therapeutics Merges With Austin-Based Biotech

Following a major clinical trial flop, San Diego’s public biotech Mast Therapeutics Inc. will merge with Austin, Texas-based Savara Inc.

Innovation Fund Makes $500,000 Investment in AristaMD

San Diego digital health company AristaMD has received a $500,000 investment from the Philadelphia College of Osteopathic Medicine’s Primary Care Innovation Fund.

Tease photo

7 Things to Know About GRAIL’s Spinout from Illumina

Illumina Inc.’s much-touted cancer test venture, GRAIL, is spinning out from its San Diego-based parent and raising $1 billion to develop its technology.

Versant Ventures Announces Leader for New Fund's Investments in San Diego, Bay Area

Versant Ventures, a global health care investment firm, announced Thursday it has appointed Clare Ozawa to lead investments in San Diego and in the Bay Area in preparation for the launch of its new $400 million fund.

Skin Care Biotech Closes $1.5 Million Funding Round

MatriSys Bioscience, a small biotechnology firm in La Jolla, has landed $1.5 million in a round led by professional angel investing group Tech Coast Angels (TCA).

Tease photo

Tina Nova’s Co. Attracts Seed Money, Key Collaboration with Pfizer Inc.

Ex-Illumina executive Tina Nova’s latest venture has landed $8.2 million in seed money and a collaboration with drug giant Pfizer Inc.